Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Bought by Oberweis Asset Management Inc.

Oberweis Asset Management Inc. boosted its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 208,760 shares of the medical instruments supplier’s stock after buying an additional 6,620 shares during the quarter. Merit Medical Systems comprises approximately 1.0% of Oberweis Asset Management Inc.’s investment portfolio, making the stock its 27th biggest holding. Oberweis Asset Management Inc.’s holdings in Merit Medical Systems were worth $20,191,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in MMSI. Barclays PLC grew its stake in shares of Merit Medical Systems by 305.4% during the third quarter. Barclays PLC now owns 112,727 shares of the medical instruments supplier’s stock valued at $11,142,000 after acquiring an additional 84,923 shares in the last quarter. EULAV Asset Management lifted its stake in Merit Medical Systems by 400.0% in the fourth quarter. EULAV Asset Management now owns 115,000 shares of the medical instruments supplier’s stock valued at $11,123,000 after buying an additional 92,000 shares during the last quarter. Pictet Asset Management Holding SA boosted its stake in Merit Medical Systems by 13.8% during the 4th quarter. Pictet Asset Management Holding SA now owns 8,675 shares of the medical instruments supplier’s stock valued at $839,000 after purchasing an additional 1,049 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Merit Medical Systems by 85.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 575,946 shares of the medical instruments supplier’s stock worth $56,921,000 after acquiring an additional 265,648 shares during the period. Finally, AMI Asset Management Corp increased its position in shares of Merit Medical Systems by 28.7% during the 4th quarter. AMI Asset Management Corp now owns 33,041 shares of the medical instruments supplier’s stock valued at $3,196,000 after purchasing an additional 7,367 shares during the period. 99.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MMSI has been the subject of several research analyst reports. Piper Sandler reduced their price objective on Merit Medical Systems from $116.00 to $112.00 and set an “overweight” rating for the company in a research note on Wednesday. Raymond James upped their target price on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. JPMorgan Chase & Co. started coverage on Merit Medical Systems in a research note on Friday, March 28th. They issued an “overweight” rating and a $120.00 price objective on the stock. Wells Fargo & Company dropped their price objective on shares of Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a report on Wednesday, February 26th. Finally, Barrington Research reiterated an “outperform” rating and set a $111.00 price target on shares of Merit Medical Systems in a research note on Friday, April 11th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $113.89.

Insider Activity at Merit Medical Systems

In related news, CFO Raul Jr. Parra sold 5,361 shares of the firm’s stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $103.58, for a total value of $555,292.38. Following the sale, the chief financial officer now directly owns 24,201 shares of the company’s stock, valued at $2,506,739.58. This trade represents a 18.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Brian G. Lloyd sold 25,000 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $99.50, for a total value of $2,487,500.00. Following the transaction, the insider now owns 38,993 shares in the company, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 109,132 shares of company stock valued at $11,139,521. 3.70% of the stock is owned by insiders.

Merit Medical Systems Trading Up 2.5 %

Merit Medical Systems stock opened at $93.76 on Thursday. The stock has a market capitalization of $5.54 billion, a P/E ratio of 45.96, a PEG ratio of 2.34 and a beta of 0.85. The stock has a 50-day simple moving average of $99.17 and a 200 day simple moving average of $100.52. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.82 and a current ratio of 5.36. Merit Medical Systems, Inc. has a 52 week low of $72.81 and a 52 week high of $111.45.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.